Maputo (n = 353) | Nampula/Nacala (n = 139) | |||||||
---|---|---|---|---|---|---|---|---|
na | Crude | Adj b % | 95% CI | na | Crude | Adj b % | 95% CI | |
Has access to new, unused syringes or needles | 315 | 89.2 | 89.6 | 85.4–93.6 | 110 | 79.7 | 78.9 | 69.6–87.2 |
Missing | 0 | – | – | 1 | – | – | ||
Had contact with a peer educator, last 12 months | 40 | 11.4 | 9.5 | 5.3–13.3 | 62 | 44.6 | 40.8 | 31.5–52.0 |
Missing | 1 | – | – | 0 | – | – | ||
Received free condoms, last 12 months | 100 | 28.6 | 26.8 | 21.0–33.7 | 88 | 63.3 | 60.0 | 49.2–71.3 |
Missing | 3 | – | – | 0 | – | – | ||
Ever received treatment for overdose, drug substitution therapy or detoxification, lifetime | 16 | 4.5 | 2.5 | 1.2–4.1 | 37 | 26.6 | 23.7 | 16.4–31.9 |
Ever in a rehabilitation or a self-help group, lifetimec | 12 | 3.4 | 2.5 | 0.9–4.8 | 26 | 18.7 | 14.3 | 7.8–22.1 |
Ever incarcerated, lifetime | 264 | 74.8 | 72.2 | 66.4–78.0 | 64 | 46.0 | 42.6 | 29.9–52.9 |
Previous HIV test, lifetime | 254 | 72.0 | 68.4 | 61.1–75.4 | 80 | 57.6 | 59.0 | 46.4–68.6 |
Previous HIV test, last 12 months | 80 | 22.9 | 24.6 | 18.9–30.0 | 35 | 25.2 | 21.9 | 12.7–31.4 |
Missing | 4 | – | – | – | 0 | – | – | |
Ever heard of Hepatitis B or C | 138 | 39.1 | 34.7 | 28.3–41.4 | 73 | 52.5 | 52.1 | 40.8–617 |
Has HIV | 179 | 56.1 | 50.1 | 40.1–59.0 | 25 | 19.8 | 19.9 | 10.9–29.2 |
Did not consent | 34 | 13 | ||||||
Screen positive for Hepatitis B surface antigen | 107 | 30.5 | 32.1 | 25.2–38.5 | 57 | 41.0 | 36.4 | 22.6–49.8 |
Did not consent | 2 | 0 | ||||||
Hepatitis C antibodies | 148 | 47.6 | 44.6 | 33.4–53.9 | 15 | 11.1 | 7.0 | 2.0–12.5 |
Did not consent | 42 | 4 | ||||||
Has HIV & HBV surface antigen | 49 | 15.4 | 14.9 | 9.1–19.5 | 10 | 7.9 | 8.3 | 2.4–14.9 |
Did not consent | 35 | 13 | ||||||
Has HIV & HCV antibodies | 116 | 38.7 | 36.1 | 26.4–45.8 | 8 | 6.5 | 4.1 | 0.6–8.4 |
Did not consent | 53 | 15 | ||||||
Ever tested positive for HIV prior to the survey | 123 | 34.9 | 29.0 | 22.1–44.3 | 10 | 7.2 | 5.8 | 1.7–11.2 |
Missing | 1 | 1 | ||||||
Had a self-reported sore or ulcer in the genital region, last 12 months | 30 | 8.5 | 8.0 | 4.7–11.7 | 35 | 25.2 | 28.6 | 19.1–37.9 |